ライフサイエンスコーパス: alternative agent

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 and then by three months of therapy with the alternative agent.

2 nts cannot tolerate it and must switch to an alternative agent.

3 t can be utilized to guide chemotherapy with alternative agents.

4 Alternative agents and approaches, including parenteral

5 been established for future trials employing alternative agents and exploration of combination therap

6 cycle of 2-CdA; 2 patients were treated with alternative agents; and 6 patients were observed.

7 istant to conventional treatment; therefore, alternative agents are needed.

8 means all studies have shown advantages over alternative agents, but concerns also remain over acute

9 r-oligomerized TRAIL may be considered as an alternative agent for testing in clinical trials.

10 ion of treatment, dosing of aminoglycosides, alternative agents for gram-positive organisms, aspirin

11 nsus guidelines recommend considering use of alternative agents for infections involving a higher van

12 ary fiber have been used as complementary or alternative agents in the management of manifestations o

13 o precise predictions about the influence of alternative agents of selection in the wild.

14 th 2.6% (22 of 851) in children treated with alternative agents (OR, 6.1 [95% CI, 1.9-16.7]).

15 Alternative agents should be considered for prophylaxis

16 Therefore, dose adjustment or use of alternative agents should be considered when strong P-gp

17 High-dose propofol should be avoided and alternative agents should be instituted for sedation and

18 A screen of alternative agents showed that both an alternative EGFR

19 udy highlights the importance of identifying alternative agents such as vascular endothelial growth f

20 lantation, concerns about toxicity have made alternative agents, such as belatacept, attractive to cl

21 concentrations (>1 or 2 microg/mL); however, alternative agents, such as telavancin, daptomycin, line

22 nclude that EGCg may represent a natural and alternative agent to the antimicrobial chemicals current

23 use of valproic acid and its derivatives as alternative agents to address the neuropsychiatric sympt

24 tudies describing the physiologic effects of alternative agents to inhaled nitric oxide.

25 20-directed Abs currently being developed as alternative agents to rituximab in CLL based upon differ

26 or whether a perioperative "bridge" with an alternative agent, typically a low-molecular-weight hepa

27 which suggest consideration of the switch to alternative agents when the isolate has a high vancomyci

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。